Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Gic-102
Non-Hodgkin Lymphoma
GI Cell, Inc.
P1/2
CCC
(48)
Gilteritinib
Acute Lymphoblastic Leukemia
Sumitomo Pharma America, Inc.
P1/2
CCC
(48)
Gilteritinib
Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer Center
P1/2
CCC
(48)
Gilteritinib
Myelodysplastic/Myeloproliferative Neoplasm
M.D. Anderson Cancer Center
P1/2
CCC
(48)
Gim-531
Melanoma
Georgiamune Inc
P1/2
CCC
(48)
Gip
Fatty Liver Disease
Dr Adnan Agha
P1/2
CCC
(48)
Glpg5101
B-Cell Non-Hodgkin Lymphoma
Lakefront Biotherapeutics NV
P1/2
CCC
(48)
Glycerol Tributyrate
MELAS Syndrome
George Washington University
P1/2
CCC
(48)
Gnc-035
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.
P1/2
CCC
(48)
Gnc-038
Extranodal Nasal NK/T Cell Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.
P1/2
CCC
(48)
Gnc-038
Non-Hodgkin Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.
P1/2
CCC
(48)
Gnc-038
Angioimmunoblastic T-Cell Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.
P1/2
CCC
(48)
Golcadomide
Peripheral T-Cell Lymphoma, Not Otherwise Specified
The Lymphoma Academic Research Organisation
P1/2
CCC
(48)
Golidocitinib
Lymphoma
Fudan University
P1/2
CCC
(48)
Golidocitinib
T-Cell Non-Hodgkin Lymphoma
Dizal Pharmaceuticals
P1/2
CCC
(48)
Gotistobart
Head And Neck Carcinoma
OncoC4, Inc.
P1/2
CCC
(48)
Gotistobart
Sarcoma
OncoC4, Inc.
P1/2
CCC
(48)
gp350 car-t
Epstein-Barr Virus-Associated Lymphoproliferative Disorder
Zhimin Zhai
P1/2
CCC
(48)
gpc3-car-t cells
Myxoid/Round Cell Liposarcoma
Sotio Biotech Inc.
P1/2
CCC
(48)
gpc3-car-t cells
Squamous Cell Lung Carcinoma
Sotio Biotech Inc.
P1/2
CCC
(48)
gpc3 cd146 car-t cells
Ovarian Sarcoma
Essen Biotech
P1/2
CCC
(48)
Grt-C903
Colorectal Cancer
National Cancer Institute (NCI)
P1/2
CCC
(48)
Grt-C903
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
Grt-R904
Colorectal Cancer
National Cancer Institute (NCI)
P1/2
CCC
(48)
Grt-R904
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
Showing 1251 to 1275 of 6,308 assets
Previous
Page 51 of 253
Next